Latest Breaking News On - Robert vonderheide - Page 5 : comparemela.com

Akamis Bio, Parker Institute for Cancer Immunotherapy, and Cancer Research Institute Announce Expanded Partnership to Advance Novel Treatments for Pancreatic Cancer

Akamis Bio's clinical-stage NG-350A tumor gene therapy to be included as a novel combination therapeutic agent in a new cohort of the REVOLUTION platform study New cohort will assess the ability of

KRAS drug stops cancer growth in preclinical models of pancreatic cancer: Study

Cancer-causing gene mutation KRAS, found in nearly 30 per cent of all human tumours, successfully shrunk tumours or stopped cancer growth in preclinical models of pancreatic cancer.

Study suggests new anti-KRAS drug as a strong candidate for pancreatic cancer clinical trials

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers from Penn Medicine's Abramson Cancer Center showed, suggesting the drug is a strong candidate for clinical trials.

KRAS drug stops cancer growth in preclinical models of pancreatic cancer: Study

KRAS drug stops cancer growth in preclinical models of pancreatic cancer: Study